Publication Date
1-2-2024
Journal
Journal of Clinical Investigation
DOI
10.1172/JCI176089
PMID
38165037
PMCID
PMC10760967
PubMedCentral® Posted Date
1-2-2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Humans, Myotonic Dystrophy, RNA Splicing, Muscle, Skeletal, Alternative Splicing, Ion Channels, Myotonin-Protein Kinase, Trinucleotide Repeat Expansion
Abstract
Myotonic dystrophy type 1 (DM1) is an autosomal dominant disorder caused by an unstable expanded CTG repeat located in the 3'-UTR of the DM1 protein kinase (DMPK) gene. The pathogenic mechanism results in misregulated alternative splicing of hundreds of genes, creating the dilemma of establishing which genes contribute to the mechanism of DM1 skeletal muscle pathology. In this issue of the JCI, Cisco and colleagues systematically tested the combinatorial effects of DM1-relevant mis-splicing patterns in vivo and identified the synergistic effects of mis-spliced calcium and chloride channels as a major contributor to DM1 skeletal muscle impairment. The authors further demonstrated the therapeutic potential for calcium channel modulation to block the synergistic effects and rescue myopathy.
Included in
Immunology of Infectious Disease Commons, Immunopathology Commons, Medical Immunology Commons, Pathology Commons